These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32597241)

  • 1. Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension.
    Bouzina H; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2021 Feb; 55(1):35-42. PubMed ID: 32597241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension.
    Arvidsson M; Ahmed A; Säleby J; Hesselstrand R; Rådegran G
    Pulm Circ; 2022 Jan; 12(1):e12041. PubMed ID: 35506077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension.
    Bouzina H; Hesselstrand R; Rådegran G
    Pulm Circ; 2019; 9(4):2045894019895446. PubMed ID: 31908768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification.
    Bouzina H; Rådegran G
    Pulm Circ; 2020; 10(3):2045894020931317. PubMed ID: 32595932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension.
    Bouzina H; Rådegran G
    ERJ Open Res; 2018 Oct; 4(4):. PubMed ID: 30443557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eye signs as a novel risk predictor in pulmonary arterial hypertension associated with systemic lupus erythematosus.
    Li J; Xiong J; Liu P; Peng Y; Cai S; Fang X; Yu S; Zhao J; Wu R
    Adv Rheumatol; 2024 Feb; 64(1):15. PubMed ID: 38424650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension.
    Arvidsson M; Ahmed A; Bouzina H; Rådegran G
    ESC Heart Fail; 2021 Apr; 8(2):1230-1243. PubMed ID: 33403810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension.
    Khirfan G; Almoushref A; Naal T; Abuhalimeh B; Dweik RA; Heresi GA; Tonelli AR
    Chest; 2020 Dec; 158(6):2546-2555. PubMed ID: 32629034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-center prognostic validation of the risk assessment of the 2015 ESC/ERS guidelines in patients with pulmonary arterial hypertension in Japan.
    Imai R; Adachi S; Yoshida M; Shimokata S; Nakano Y; Okumura N; Murohara T; Kondo T
    Can J Physiol Pharmacol; 2020 Sep; 98(9):653-658. PubMed ID: 32924564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.
    Simpson CE; Damico RL; Hassoun PM; Martin LJ; Yang J; Nies MK; Vaidya RD; Brandal S; Pauciulo MW; Austin ED; Ivy DD; Nichols WC; Everett AD
    Chest; 2020 Jun; 157(6):1606-1616. PubMed ID: 31987881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension.
    Nickel NP; Lichtinghagen R; Golpon H; Olsson KM; Brand K; Welte T; Hoeper MM
    Respir Res; 2013 Nov; 14(1):130. PubMed ID: 24251953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
    Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
    BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
    Yokokawa T; Boucherat O; Martineau S; Lemay SE; Breuils-Bonnet S; Krishna V; Kalyana-Sundaram S; Jeyaseelan J; Potus F; Bonnet S; Provencher S
    J Am Heart Assoc; 2024 Jun; 13(12):e032888. PubMed ID: 38874078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
    Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
    Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
    Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.